ATE404560T1 - Indazol- und indolonderivative und deren verwendung als pharmazeutika - Google Patents

Indazol- und indolonderivative und deren verwendung als pharmazeutika

Info

Publication number
ATE404560T1
ATE404560T1 AT05742759T AT05742759T ATE404560T1 AT E404560 T1 ATE404560 T1 AT E404560T1 AT 05742759 T AT05742759 T AT 05742759T AT 05742759 T AT05742759 T AT 05742759T AT E404560 T1 ATE404560 T1 AT E404560T1
Authority
AT
Austria
Prior art keywords
pharmaceutics
indazole
indolone derivatives
indolone
derivatives
Prior art date
Application number
AT05742759T
Other languages
English (en)
Inventor
Charlotte Moira Norfo Allerton
David Hepworth
Duncan Charles Miller
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411810A external-priority patent/GB0411810D0/en
Priority claimed from GB0415455A external-priority patent/GB0415455D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE404560T1 publication Critical patent/ATE404560T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05742759T 2004-05-26 2005-05-17 Indazol- und indolonderivative und deren verwendung als pharmazeutika ATE404560T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0411810A GB0411810D0 (en) 2004-05-26 2004-05-26 New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en) 2004-07-09 2004-07-09 New indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
ATE404560T1 true ATE404560T1 (de) 2008-08-15

Family

ID=35219654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05742759T ATE404560T1 (de) 2004-05-26 2005-05-17 Indazol- und indolonderivative und deren verwendung als pharmazeutika

Country Status (25)

Country Link
EP (1) EP1753763B1 (de)
JP (2) JP4093588B2 (de)
AP (1) AP2006003823A0 (de)
AR (1) AR049191A1 (de)
AT (1) ATE404560T1 (de)
AU (1) AU2005247696A1 (de)
BR (1) BRPI0511533A (de)
CA (1) CA2568050A1 (de)
CR (1) CR8772A (de)
DE (1) DE602005008954D1 (de)
EA (1) EA200601985A1 (de)
EC (1) ECSP067024A (de)
ES (1) ES2308492T3 (de)
GT (1) GT200500118A (de)
IL (1) IL179365A0 (de)
MA (1) MA28606B1 (de)
MX (1) MXPA06013759A (de)
NL (1) NL1029128C2 (de)
NO (1) NO20065328L (de)
PA (1) PA8635001A1 (de)
PE (1) PE20060289A1 (de)
SV (1) SV2005002128A (de)
TW (1) TW200607500A (de)
UY (1) UY28918A1 (de)
WO (1) WO2005116027A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078411A1 (es) 2009-05-07 2011-11-09 Lilly Co Eli Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
US9259409B2 (en) * 2011-01-24 2016-02-16 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions
CA2965741C (en) * 2014-11-03 2022-05-17 Iomet Pharma Ltd Pharmaceutical compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
WO1998035942A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 4-aminoethoxyindazole derivatives
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
JP3889775B2 (ja) * 2002-12-10 2007-03-07 ファイザー・インク Ｉ．ａ．性機能障害の治療においてドパミンアゴニストとして使用するためのモルホリン誘導体

Also Published As

Publication number Publication date
AU2005247696A1 (en) 2005-12-08
EP1753763B1 (de) 2008-08-13
MXPA06013759A (es) 2007-02-08
NL1029128C2 (nl) 2006-06-14
WO2005116027A2 (en) 2005-12-08
IL179365A0 (en) 2007-03-08
CR8772A (es) 2006-12-13
SV2005002128A (es) 2005-12-13
CA2568050A1 (en) 2005-12-08
EA200601985A1 (ru) 2007-04-27
NO20065328L (no) 2006-12-18
EP1753763A2 (de) 2007-02-21
AP2006003823A0 (en) 2006-12-31
BRPI0511533A (pt) 2008-01-02
PE20060289A1 (es) 2006-04-22
NL1029128A1 (nl) 2005-11-30
AR049191A1 (es) 2006-07-05
TW200607500A (en) 2006-03-01
WO2005116027A3 (en) 2006-04-13
UY28918A1 (es) 2005-12-30
GT200500118A (es) 2006-01-10
JP2008074874A (ja) 2008-04-03
PA8635001A1 (es) 2006-05-16
JP4093588B2 (ja) 2008-06-04
MA28606B1 (fr) 2007-05-02
JP2008500329A (ja) 2008-01-10
ES2308492T3 (es) 2008-12-01
DE602005008954D1 (de) 2008-09-25
ECSP067024A (es) 2006-12-29

Similar Documents

Publication Publication Date Title
ATE543808T1 (de) 5,6-ring-annelierte indolderivate und ihre verwendung
ATE378338T1 (de) Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten
ATE430754T1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE602005023639D1 (de) Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten
DE602005015699D1 (de) Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
DE602005022115D1 (de) Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
ATE471938T1 (de) Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
ATE520686T1 (de) Azabicycloä3.1.0ühexanderivate und ihre verwendung als modulatoren des dopamin-d3- rezeptors
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE602005016162D1 (de) Benzimidazolderivate und ihre Verwendung als AII Rezeptor-Antagonist
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
ATE473214T1 (de) 2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonisten
ATE529420T1 (de) 3-ä(2-ää4-hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester-methansulfonat-hemihydrat und dessen verwendung als arzneimittel
ATE517098T1 (de) Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren
ATE396185T1 (de) Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
ATE420084T1 (de) Neue imidazolderivate und deren verwendung als pharmazeutische mittel
DE602005022060D1 (de) Diaminoalkohole und deren verwendung als renininhibitoren
DE50311397D1 (de) Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren
DE602007008572D1 (de) Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
ATE468338T1 (de) Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
DE602005007866D1 (de) 1-phenyl- und 1-pyridylpyrazolderivate und deren verwendung als pestizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties